思略特：2024用人工智能重新发明医药报告（英文版）

We expect the future of pharma and healthcare to be personalized and digital, with increasingly blurred boundaries between prevention and treatment. Artificial intelligence (AI) is accelerating this convergence of pharma, broader healthcare, technology and consumer products and generates great benefits for each sector. Pharmaceutical companies can lead the way and incorporate AI into new products and services directly, or profit indirectly by using AI to make processes more productive an